Considering the clinical trajectory of CLL, particularly in RT, we observed a statistically significant upregulation of MYC target genes in RT compared to pre-RT stages (p = 0.015) (Figure 1c). Here, MYC is linked to B-cell chronic lymphocytic leukemia.